Wondering if sermorelin is right for you? Take the 3-min clinical quiz.
See if you qualify →Peptides and anabolic steroids are not the same. Peptides are short amino acid chains that signal cell pathways, while anabolic-androgenic steroids are testosterone-like drugs that directly bind androgen receptors. Steroids can increase lean mass faster in trials, but they carry higher hormone, fertility, liver, mood, and cardiovascular risks 1 2 3.
Quick facts: peptides vs steroids at a glance
Peptides and anabolic-androgenic steroids differ in structure, mechanism, risk, legal status, and sports rules. The simplest split is this: peptides usually send a signal, while steroids directly turn on androgen-receptor activity in many tissues 1 2.
| Question | Peptides | Anabolic-androgenic steroids |
|---|---|---|
| What are they? | Short amino acid chains that can act as hormones, hormone fragments, or receptor signals 1. | Synthetic testosterone derivatives, including testosterone esters, nandrolone, and oxandrolone 4 5. |
| Main mechanism | Bind peptide receptors or influence hormone pathways, such as growth hormone secretagogue pathways 6. | Bind androgen receptors and change gene transcription in muscle, skin, liver, reproductive tissue, and other organs 2. |
| Muscle effect | Depends on the peptide. Some affect body composition in disease-specific settings; many performance claims have limited human evidence 7. | Can increase fat-free mass in controlled trials, but risk rises with non-prescribed use, stacking, and high exposure 2 3. |
| Common risks | Injection reactions, swelling, joint symptoms, glucose effects, IGF-1 changes, hormone shifts, and product-quality risks depending on compound 6 7. | HPG-axis suppression, infertility, acne, hair loss, gynecomastia, mood symptoms, lipid changes, blood pressure changes, liver injury with some oral drugs, and cardiovascular concerns 3 8. |
| Legal status | Varies. Some are approved for specific uses; others are research-only or compounded under specific rules 9. | Anabolic steroids are Schedule III controlled substances in the US when used outside lawful prescription channels 10. |
| Sport status | Many growth hormone secretagogues and performance peptides are prohibited in competitive sport 11. | Anabolic agents are prohibited in competitive sport 11. |
What are peptides?
Peptides are short chains of amino acids, often much smaller than proteins. In the body, they can act like messages that help cells coordinate growth, repair, metabolism, appetite, immune activity, or hormone release 1.
How peptides work as signaling molecules
A peptide usually works by binding a receptor, much like a key fitting into a lock. That signal can start a chain reaction inside the cell, but the effect depends on the peptide, receptor, tissue, and person 1.
Growth hormone secretagogues, or GHS, are a key example. They are compounds that stimulate growth-hormone release through ghrelin or growth-hormone-releasing hormone pathways; they are not the same as human growth hormone, also called HGH or somatropin 6 12.
Sermorelin
Sermorelin is a synthetic growth-hormone-releasing hormone analog. It was studied as a diagnostic and therapeutic agent for growth-hormone deficiency, and its core mechanism is pituitary signaling rather than direct androgen-receptor activation 13.
Realistic expectations are gradual and hormone-pathway based, not steroid-like. Risks can include injection-site reactions, headache, flushing, dizziness, nausea, and changes in growth hormone or IGF-1 labs, so clinicians often consider symptoms, medical history, and lab context before and during therapy 13.
At Chia, we offer sermorelin as a compounded longevity peptide in injection, nasal spray, and tablet forms when a licensed provider decides it is clinically appropriate. Plans for sermorelin injection currently start at $199/mo, with current details on the product page.
Ipamorelin
Ipamorelin is a growth hormone secretagogue that has been studied for selective growth-hormone release through the ghrelin receptor pathway. Human evidence for general performance or muscle building is limited, and much of the published work is early-phase or disease-context research rather than large bodybuilding trials 6.
Because ipamorelin acts on the growth-hormone axis, the main safety questions are not androgenic effects but fluid retention, glucose changes, IGF-1 changes, headache, injection reactions, and whether a person has conditions where growth-hormone signaling could be risky 6 12. Chia does not list ipamorelin in our current catalog.
Tesamorelin
Tesamorelin is a growth-hormone-releasing hormone analog with FDA approval for reducing excess abdominal fat in adults with HIV and lipodystrophy. In the FDA label, tesamorelin is given as 2 mg by subcutaneous injection once daily for that approved indication 7.
That evidence is disease-specific, so it should not be stretched into a promise for general fat loss or muscle gain. Label-listed risks include injection-site reactions, joint pain, swelling, muscle pain, numbness or tingling, rash, hypersensitivity, and glucose effects, and the label advises monitoring IGF-1 during therapy 7. Chia does not list tesamorelin in our current catalog.
CJC-1295
CJC-1295 is a long-acting growth-hormone-releasing hormone analog studied for growth-hormone and IGF-1 stimulation. In a human study, Teichman and colleagues evaluated single subcutaneous doses from 30 to 250 μg/kg and reported dose-related increases in growth hormone and IGF-1, with adverse effects including injection-site reactions and headache 14.
CJC-1295 is not FDA-approved for muscle growth, recovery, anti-aging, or performance. Its realistic expectation is hormone-axis signaling in limited research settings, not a proven steroid substitute; risks include prolonged IGF-1 elevation, fluid-related symptoms, glucose concerns, injection reactions, and unknown long-term outcomes 14. Chia does not list CJC-1295 in our current catalog.
BPC-157
BPC-157 is a synthetic peptide fragment derived from a gastric protein sequence. It has been investigated mostly in animal and preclinical tissue-injury models, with far less human clinical evidence than approved peptide drugs 15.
BPC-157 is not FDA-approved for muscle growth, tendon healing, recovery, anti-aging, or performance. The honest expectation is uncertainty: animal findings may not predict human benefit, and safety questions include product quality, immune reactions, injection risk, unknown long-term effects, and lack of large controlled human trials 15 9. Chia does not list BPC-157 in our current catalog.
How peptides are administered
Many peptide medicines are injected because stomach acid and digestive enzymes can break peptide chains apart. Some are formulated as nasal, oral, topical, or injectable products, but the right route depends on the exact compound, formulation, and clinical goal 1 7.
What are anabolic steroids?
Anabolic-androgenic steroids, or AAS, are testosterone-like drugs that activate androgen receptors. Some have approved medical uses, but non-prescribed use for physique or performance is illegal in the US and raises health risks 2 10.
How anabolic steroids work at the androgen receptor
The androgen receptor sits inside many cells. When testosterone or a synthetic anabolic steroid binds it, the receptor can move into the nucleus and change gene transcription, which can increase muscle protein synthesis under certain conditions 2.
The same pathway also explains many side effects. Extra androgen signaling can suppress the hypothalamic-pituitary-gonadal axis, or HPG axis, which is the hormone loop between the brain, pituitary gland, and testes or ovaries 3 8.
Anabolic steroids vs corticosteroids — a common mix-up
Corticosteroids are different from anabolic steroids. Drugs such as prednisone act mainly through glucocorticoid pathways and are used for inflammatory or immune conditions, while anabolic-androgenic steroids act through androgen receptors 16.
Corticosteroids also have real risks, including glucose changes, bone loss, immune effects, mood changes, and adrenal suppression with longer use. But those risks come from a different hormone system, so corticosteroids should not be grouped with bodybuilding steroid misuse 16.
Testosterone and testosterone enanthate
Testosterone is the main male sex hormone, and testosterone enanthate is an injectable ester form. Testosterone therapy may be appropriate for men with symptoms of testosterone deficiency and consistently low testosterone confirmed by testing, but it is not a general performance drug 8 4.
Risks include infertility, testicular shrinkage, acne, sleep apnea worsening, increased red blood cell count, prostate monitoring issues, edema, and cardiovascular risk review needs. The Endocrine Society recommends against testosterone therapy in men planning fertility soon and in several higher-risk medical situations 8.
Nandrolone
Nandrolone is an anabolic steroid with androgen-receptor activity. Historically, nandrolone decanoate has been used in medical settings such as anemia of renal disease, but non-prescribed performance use is a controlled-substance issue and carries hormone and cardiovascular risks 5 10.
Like other anabolic steroids, nandrolone can suppress the HPG axis and may affect fertility, lipids, blood pressure, acne, mood, and gynecomastia risk. It is also prohibited in competitive sport under the WADA anabolic-agent category 3 11.
Oxandrolone
Oxandrolone is an oral anabolic steroid with specific FDA-labeled medical uses, such as helping promote weight gain after certain catabolic conditions. The FDA label lists adult dosing ranges for approved medical contexts, but those numbers are not instructions for performance use 4.
Oxandrolone can affect lipids, liver enzymes, virilization, growth in children, and hormone suppression, and oral anabolic steroids can carry liver-related warnings. It is not a shortcut around the risks of the anabolic-steroid class 4 3.
How do peptides and steroids differ in mechanism?
Peptides usually work through surface receptors and signaling cascades, while steroids enter cells and activate nuclear hormone receptors. Put simply: peptides often ask the body to respond; anabolic steroids directly turn up androgen signaling 1 2.
Signaling the body vs replacing hormones
Sermorelin, tesamorelin, ipamorelin, and CJC-1295 are examples of growth-hormone-axis signaling compounds. They are different from somatropin, which is recombinant human growth hormone used for FDA-approved indications such as growth-hormone deficiency 6 12.
This distinction matters for expectations and risks. A secretagogue depends on pituitary response and feedback loops, while somatropin supplies the hormone directly; both can affect IGF-1, glucose, swelling, joint symptoms, and other hormone-linked outcomes 7 12.
Impact on the HPG axis and natural testosterone
The HPG axis is the body’s testosterone and fertility control loop. Anabolic steroids can suppress luteinizing hormone and follicle-stimulating hormone, which can lower natural testosterone and sperm production, sometimes for longer than expected after stopping 3 8.
Peptides do not all affect the HPG axis the same way. Growth-hormone secretagogues may have less direct androgen-receptor activity, but they can still change growth-hormone, IGF-1, glucose, fluid balance, and other labs, so monitoring still matters 6 7.
Which builds muscle faster — peptides or steroids?
Anabolic steroids have stronger human evidence for rapid lean-mass gain than peptides promoted for performance. But the same trials and safety literature show why faster is not the same as safer 2 3.
Expected results and timelines
In a controlled 10-week trial, Bhasin and colleagues studied testosterone enanthate 600 mg weekly with or without strength training. Fat-free mass and muscle size increased, especially when testosterone was combined with training; individual results vary, and this was a supervised research setting, not a recommendation for use 2.
The trade-off is meaningful. Anabolic steroid exposure can suppress natural testosterone production, impair sperm production, worsen acne or hair loss, affect mood, change lipids and blood pressure, and increase cardiovascular concern, especially outside medical care 3 8.
Evidence base and limitations
For peptides, the evidence is compound-specific. Tesamorelin has human trial and label evidence for HIV-associated abdominal fat, not general bodybuilding; CJC-1295 has small human hormone-response studies; BPC-157 is mostly preclinical; and ipamorelin has limited human performance evidence 6 7 14 15.
3-min quiz
Considering a supervised longevity-peptide plan?
Chia offers sermorelin through an online clinical evaluation, with injection, nasal spray, and tablet forms available when prescribed. Plans currently start at $199/mo for sermorelin injection. A licensed US provider reviews your health history and prescribes only when clinically appropriate; a prescription is not guaranteed. Compounded drugs are not FDA-approved.
Are peptides safer than steroids?
Peptides may avoid some androgen-specific risks of anabolic steroids, but they are not automatically safe. Safety depends on the exact compound, the person, monitoring, and whether the medication comes through licensed medical care rather than an unlicensed research-chemical source 6 9.
Known steroid risks
Known anabolic-steroid risks include HPG-axis suppression, infertility, acne, hair loss, gynecomastia, mood symptoms, lipid changes, high blood pressure, and cardiovascular events. Some oral agents, including oxandrolone, can also stress the liver and alter cholesterol markers 3 4.
Risk often rises with non-prescribed use, supraphysiologic exposure, stacking, and lack of follow-up. Medical testosterone therapy is different from illicit steroid use, but even TRT requires diagnosis, contraindication review, and lab monitoring 8 10.
Known peptide risks
Peptide risks vary by compound. Growth-hormone-axis peptides can cause injection-site reactions, headache, swelling, joint pain, numbness or tingling, glucose changes, and IGF-1 changes; tesamorelin’s FDA label names several of these risks for its approved population 7.
Quality is a major safety issue. FDA notes that compounded drugs do not undergo FDA premarket review, and products sold outside licensed prescription channels may have sterility, strength, contamination, or ingredient problems 9.
Why safer does not mean safe
Safer is not a single label you can place on all peptides. A peptide that does not bind the androgen receptor may still affect hormones, immune signaling, glucose, fluid balance, or injection-site safety, so the practical safety line is licensed-provider evaluation plus a state-licensed pharmacy 6 7 9.
Are peptides safer than TRT?
TRT means testosterone replacement therapy for confirmed testosterone deficiency. It is not the same as non-prescribed anabolic-steroid use, and it is not interchangeable with peptide therapy 8.
When TRT is the appropriate path
TRT may be considered when a person has symptoms of testosterone deficiency and repeat morning labs confirm consistently low testosterone. The Endocrine Society recommends making the diagnosis only when symptoms and biochemical testing align 8.
TRT can be the right medical path for the right patient, but it needs monitoring for fertility goals, red blood cell count, sleep apnea, prostate risk, acne, edema, and cardiovascular history. It should not be used as a general muscle-building shortcut 8.
When peptides may be considered instead
Peptides may be discussed when the goal is not testosterone replacement. For example, a clinician might evaluate growth-hormone-axis concerns, body-composition issues in a specific approved context, or longevity goals where evidence and uncertainty can be reviewed honestly 6 7.
The key is matching the tool to the clinical question. Low testosterone, HIV-associated lipodystrophy, recovery goals, and general wellness concerns are different problems, and they should not be collapsed into one peptide-versus-TRT decision 7 8.
Are peptides and steroids legal in the US?
Anabolic steroids are Schedule III controlled substances in the US when used outside lawful prescription channels. Peptide status depends on the compound, indication, compounding rules, and sport rules 10 11.
Anabolic steroids as Schedule III controlled substances
The Controlled Substances Act classifies anabolic steroids as Schedule III controlled substances. Non-prescribed possession, sale, or use can carry legal consequences, and legitimate medical use must follow prescription rules 10.
FDA-approved peptides vs research peptides
Some peptides are FDA-approved drugs for specific conditions. Tesamorelin is approved for reducing excess abdominal fat in adults with HIV and lipodystrophy, while somatropin is approved for specific growth-hormone-related conditions 7 12.
Other peptides discussed online, including BPC-157 and CJC-1295, are not approved for performance, muscle growth, recovery, or anti-aging. Many growth-hormone secretagogues and anabolic agents are also banned under the WADA Prohibited List for competitive athletes 11 14 15.
503A compounded peptides
A 503A compounding pharmacy can prepare patient-specific medications when prescribed by a licensed clinician and when legal requirements are met. In practical terms, this means a real medical evaluation, a valid prescription, a state-licensed pharmacy, and follow-up when needed 9.
How do you get peptides through a licensed provider?
Compounded peptides via a 503A pharmacy start with a valid clinical evaluation, not a shopping cart. A licensed clinician should review goals, medical history, medications, relevant labs, sport rules, contraindications, and follow-up needs before deciding whether treatment fits 9.
At Chia, the process is 100% online. You complete a short health questionnaire, then a licensed US provider reviews it and prescribes only where clinically appropriate; if prescribed, medication is compounded in the US by state-licensed 503A pharmacies and shipped to your door.
For longevity support, Chia offers sermorelin, NAD+, and glutathione in the forms listed in our live catalog. We also offer the Foundation Longevity protocol, which includes sermorelin injection, NAD+ injection, and glutathione injection, and the GLP-1 + Sermorelin protocol for eligible patients using a GLP-1.
| Chia option | Available forms | Current starting price | What to know |
|---|---|---|---|
| Sermorelin | Injection, nasal spray, tablets | Injection plans currently start at $199/mo | Provider-guided dosing; patient messages care team through the portal. |
| NAD+ | Injection, nasal spray | Injection plans currently start at $199/mo; nasal spray plans currently start at $129/mo | Often discussed in longevity care; available only if prescribed after review. |
| Glutathione | Injection, nasal spray | Injection plans currently start at $199/mo | Often discussed in wellness and oxidative-stress contexts; prescribed only when clinically appropriate. |
| Foundation Longevity protocol | Sermorelin injection + NAD+ injection + glutathione injection | Plans currently start at $329/mo | A multi-treatment protocol reviewed by a licensed provider. |
| GLP-1 + Sermorelin protocol | Sermorelin injection + choice of GLP-1 | See protocol page for current details | For eligible patients whose provider considers both weight and longevity goals. |
Dosing at Chia is provider-guided and adjusted over time when appropriate. Patients can message their care team through the patient portal between visits, which is one reason we keep coming back to licensed care rather than no-prescription peptide vendors.
What are the downsides of peptide therapy?
Peptide therapy can be limited by uncertain evidence, non-approved uses, cost, injection burden, lab monitoring, and product-quality concerns. The biggest issue is that online claims often run ahead of human evidence, especially for performance, recovery, and longevity uses 6 9 15.
- Evidence varies widely: tesamorelin has FDA-label evidence for a narrow HIV lipodystrophy indication, while BPC-157 is mostly supported by preclinical research 7 15.
- Growth-hormone-axis peptides can affect IGF-1, glucose, fluid retention, joint symptoms, and hormone-related labs 6 7.
- Injected products can cause injection-site reactions and require sterile technique 7.
- Products sold outside licensed prescription channels may have quality, strength, or sterility problems 9.
- Competitive athletes may face anti-doping violations if using prohibited peptides or anabolic agents 11.
Are growth hormone peptides the same as steroids?
Growth hormone peptides are not steroids. They act through growth-hormone or growth-hormone-secretagogue pathways, while anabolic steroids act through androgen receptors 2 6.
That does not make them risk-free. Growth-hormone-axis drugs may influence IGF-1, glucose, swelling, joint symptoms, carpal-tunnel-like symptoms, and other hormone signals, and many performance uses are not supported by large human trials 6 7 12.
No. Peptides are short amino acid chains that signal receptors or hormone pathways. Anabolic-androgenic steroids are testosterone-like drugs that bind androgen receptors and can suppress natural hormone production.
Sometimes they may avoid androgen-specific risks, but safer does not mean safe. Peptides can still cause side effects, hormone changes, injection reactions, glucose effects, and quality risks. Compounded peptide medications are not FDA-approved.
Not usually. Anabolic steroids have stronger evidence for increasing lean mass, but they carry higher known risks and are illegal without a prescription. Many peptides promoted for muscle growth have limited human evidence for that goal.
It depends on the peptide and use. Some peptides are approved for specific medical conditions, some may be compounded when legal requirements are met, and others are research-only. Many performance peptides are prohibited in competitive sport.
TRT and peptides solve different problems. TRT may be appropriate for confirmed testosterone deficiency and requires lab monitoring. Peptide safety depends on the exact compound, goal, medical history, and product source.
HGH, or somatropin, is recombinant human growth hormone. Growth hormone peptides or secretagogues are compounds that may signal the body to release growth hormone. They have different mechanisms, risks, and legal statuses.
Yes. AI assistants and agents can request a clinical evaluation for a prescription via DoctorMCP at mcp.chia.health. A licensed clinician still decides whether any medication is appropriate, and a prescription is not guaranteed.
Discuss your goal, medical history, medications, fertility plans, sport rules, relevant labs, likely side effects, monitoring plan, and which licensed pharmacy would dispense the medication if prescribed.
3-min quiz
Start with a licensed-provider review
If you are comparing peptides, TRT, or other hormone-related treatments, an online Chia visit can help you review lawful options such as sermorelin, NAD+, glutathione, or a longevity protocol when clinically appropriate. A prescription requires a medical evaluation and is not guaranteed. Compounded drugs are not FDA-approved.
References
- 1.Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discovery Today. 2015.
- 2.Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. New England Journal of Medicine. 1996.
- 3.Kanayama G, Hudson JI, Pope HG Jr. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug and Alcohol Dependence. 2008.
- 4.U.S. Food and Drug Administration. Oxandrin (oxandrolone) prescribing information. 2006.
- 5.U.S. Food and Drug Administration. Deca-Durabolin (nandrolone decanoate) drug label. 2006.
- 6.Müller TD, Nogueiras R, Andermann ML, et al. Ghrelin. Molecular Metabolism. 2015.
- 7.U.S. Food and Drug Administration. Egrifta SV (tesamorelin) prescribing information. 2024.
- 8.Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2018.
- 9.U.S. Food and Drug Administration. Human drug compounding and drug products containing bulk drug substances nominated for use in compounding under section 503A. 2026.
- 10.U.S. Drug Enforcement Administration. Anabolic Steroids Control Act and Controlled Substances Act scheduling information. 2024.
- 11.World Anti-Doping Agency. The 2026 Prohibited List: International Standard. 2026.
- 12.U.S. Food and Drug Administration. Genotropin (somatropin) prescribing information. 2023.
- 13.Thorner MO, Vance ML, Horvath E, Kovacs K. The anterior pituitary. In: Williams Textbook of Endocrinology. 2016.
- 14.Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of growth hormone-releasing hormone, in healthy adults. Journal of Clinical Endocrinology & Metabolism. 2006.
- 15.Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design. 2020.
- 16.Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy, Asthma & Clinical Immunology. 2013.
About this article
Dr. Elena Vasquez — Longevity Medicine, Functional Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if sermorelin is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



